Common Complications And Clinical Solution Experience Of AVF Needle Application

Common Clinical Complication Pain Points

Long-term application of AVF needles in hemodialysis is accompanied by various common complications, which are key pain points restricting the improvement of patient dialysis quality. The most frequent complications include puncture site bleeding and hematoma, vascular intimal hyperplasia, AVF stenosis and occlusion, local infection and thrombosis. Puncture bleeding and hematoma are mostly caused by non-standard puncture operation and improper postoperative hemostasis, which not only increases patient pain, but also affects the patency of local blood vessels. Long-term repeated puncture damage will induce intimal hyperplasia, resulting in narrowing of fistula vascular diameter, insufficient dialysis blood flow, and reduced treatment efficiency. Severe stenosis will further lead to AVF occlusion, forcing patients to rebuild vascular access, which brings great physical pain and economic pressure. Local bacterial infection caused by incomplete disinfection and non-standard needle disposal will cause puncture site redness, swelling, and suppuration, and even induce systemic blood infection in severe cases. Thrombosis is caused by vascular intimal damage and slow blood flow, which directly endangers the survival of AVF. These complications form a vicious cycle in clinical treatment and seriously affect the long-term prognosis of CKD patients.

Complication Occurrence Principle and Mechanism

The occurrence of various AVF needle-related complications has clear pathological and mechanical principles. Bleeding and hematoma are caused by vascular wall tearing and incomplete wound closure after improper puncture angle and excessive puncture force damage the integrity of the vascular wall. Vascular intimal hyperplasia is a compensatory pathological reaction of blood vessels after long-term mechanical stimulation of repeated puncture; continuous friction and damage of the needle body to the intima will stimulate the proliferation of vascular smooth muscle cells, resulting in thickening of the intima and narrowing of the vascular lumen. AVF stenosis and occlusion are the final results of long-term intimal hyperplasia and local cumulative damage. Infection complications originate from the invasion of external pathogenic bacteria into the subcutaneous tissue and blood vessels through the puncture wound, which is closely related to incomplete preoperative disinfection and non-aseptic operation. Thrombosis formation is based on vascular intimal damage; the damaged intima will activate the body's coagulation mechanism, coupled with slow local blood flow, resulting in platelet aggregation and thrombus formation, blocking the fistula vascular lumen.

Classification Analysis of Complication Types and Causes

According to the occurrence time and severity, AVF needle-related complications are divided into acute complications and chronic complications. Acute complications occur during or immediately after dialysis, including puncture bleeding, subcutaneous hematoma, and acute infection, which are mainly caused by operational irregularities and improper postoperative care. Bleeding is mostly due to needle displacement and incomplete hemostasis; hematoma is caused by vascular wall penetration and blood extravasation; acute infection is induced by incomplete skin disinfection and contaminated needle equipment. Chronic complications occur after long-term repeated puncture use, including intimal hyperplasia, vascular stenosis, chronic thrombosis, and aneurysm formation. The main causes are unreasonable needle selection, long-term fixed-point puncture, and cumulative mechanical damage to blood vessels. Aneurysm is formed by long-term local vascular wall thinning and expansion caused by repeated puncture at the same site, which is easy to rupture and bleed in severe cases, bringing great safety risks to patients.

Standard Prevention and Solution Operation Guidelines

Aiming at different types of complications, the industry has formed standardized prevention and solution operation guidelines. For acute bleeding and hematoma: standardize puncture angle and force, avoid vascular wall penetration; after needle withdrawal, implement standardized compression hemostasis, master accurate compression position and time, and apply ice compress within 24 hours of hematoma occurrence to reduce bleeding and swelling. For acute infection: strictly implement preoperative aseptic disinfection, use qualified sterile AVF needles, keep the puncture site clean and dry after operation, and apply antibiotic ointment locally for mild infection. For chronic intimal hyperplasia and stenosis: adhere to rope-ladder decentralized puncture, select low-damage safety needles, avoid long-term local vascular stimulation, and regularly monitor vascular patency. For thrombosis: optimize needle specifications to ensure sufficient dialysis blood flow, avoid slow blood flow caused by small-gauge needles, and carry out regular anticoagulant nursing according to patient conditions. For aneurysm: strictly prohibit fixed-point repeated puncture, adjust puncture sites in time, and protect weakened vascular segments.

Clinical Practical Experience of Complication Management

Long-term clinical practice has accumulated mature experience in complication prevention and treatment of AVF needles. First, full-cycle vascular access assessment is implemented for patients, and needle types and puncture modes are dynamically adjusted according to vascular changes, which can reduce the incidence of chronic complications by more than 60%. Second, establish a patient personal vascular access file, record each puncture site, needle specification, and complication situation, realize traceable management, and avoid repeated damage to high-risk vascular sites. Third, strengthen postoperative follow-up nursing, guide patients to protect the puncture site, avoid extrusion and water immersion, and reduce infection risks. Fourth, for patients with recurrent hematoma and stenosis, upgrade to safety plastic cannulas in time to reduce vascular mechanical damage. Clinical data shows that through standardized complication prevention and targeted intervention, the one-year patency rate of patient AVF can be increased from 75% to more than 92%, and the incidence of severe complications is significantly reduced.

Summary and Prevention Prospect Suggestions

Complication prevention and control is an important part of the clinical application management of AVF needles. Most AVF-related dialysis complications are caused by non-standard operation, unreasonable needle selection, and insufficient daily protection, which are completely preventable through standardized management. At present, the industry's insufficient attention to chronic complication prevention and imperfect whole-process intervention system are the main problems in clinical management. In the future, medical institutions should build a full-cycle complication prevention system covering preoperative evaluation, intraoperative standard operation, postoperative nursing, and long-term follow-up. The industry should promote the popularization of low-damage safety AVF needles, optimize product design to reduce mechanical damage and infection risks. At the same time, strengthen patient health education, improve patients' self-protection awareness of vascular access, form a joint prevention and control mechanism of medical staff and patients, and comprehensively improve the safety and stability of long-term hemodialysis treatment.